XM does not provide services to residents of the United States of America.
D
D

DassaultSystem

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

STOXX pauses, defence keeps running

LIVE MARKETS-STOXX pauses, defence keeps running STOXX 600 down 0.1% Inflation data eyed this week Ageas drops Direct Line buyout plans Wall Street futures inch lower Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com STOXX PAUSES, DEFENCE KEEPS RUNNING Shares in Europe got off to a rater uneventful start on Monday, with the STOXX 600 .STOXX pausing for breath after a quarter of gai
A
D
L
R
D
F
U
G

Visiativ FY EBITDA Margin At 9.8%, Acquires Solid Apps

BRIEF-Visiativ FY EBITDA Margin At 9.8%, Acquires Solid Apps March 19 (Reuters) - Visiativ SA ALVIV.PA : FY EBITDA MARGIN OF 9.8% FY ARR OF SAAS SUBSCRIPTIONS AT 31 DECEMBER 2023: EUR 40.1M, UP 46% INTERNATIONAL SALES OF EUR 100 MILLION IN 2023, I.E. 36% OF GROUP ACTIVITY BY 2028, VISIATIV IS TARGETING SALES OF €500M, 50% OF WHICH WILL BE GENERAT
D

France's billionaire tycoons and their media interests

FACTBOX-France's billionaire tycoons and their media interests PARIS, March 15 (Reuters) - French billionaire Rodolphe Saade , whose family controls giant shipping company CMA CGM, said on Friday he had agreed to pay 1.55 billion euros ($1.69 billion) for Altice Media, owner of BFM TV news channel and RMC radio stations, from another French tycoon, Patrick Drahi.
B
B
D
K
L
V

Colonial, Covivio SA, Fluidra SA

EUROPE RESEARCH ROUNDUP-Colonial, Covivio SA, Fluidra SA March 5 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Colonial, Covivio SA and Fluidra SA on Tuesday. HIGHLIGHTS * Colonial COL.MC : Jefferies raises to hold from underperform * Covivio SA CVO.PA : Jefferies raises to buy from hold * Fluidra SA FLUI.MC : Jefferies cuts to hold from buy * KBC Groep NV KBC.BR : Berenberg raises to buy from hold * Vivoryon Therapeutics NV VVY.
A
A
A
A
A
B
C
D
E
E
E
G
G
H
H
I
I
K
K
L
N
S
S
S
A
A
A
A
I
L
R

Ansys beats fourth-quarter estimates on robust software demand

Ansys beats fourth-quarter estimates on robust software demand Feb 21 (Reuters) - Ansys ANSS.O beat Wall Street estimates for fourth-quarter revenue and profit on Wednesday, driven by growing demand for its engineering software solutions, used to make a range of products such as airplanes and tennis rackets. The Pittsburgh, Pennsylvania-based company's shares rose nearly 2% in extended trading.
A
D
N

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.